Injectable Medications That Lower Blood Sugar and Aid Weight Loss
GLP-1 receptor agonists are a non-insulintype 2 diabetesmedication.
GLP-1 agonists help to lower blood sugar and aid in weight loss.
This article discusses GLP-1 agonists.
fertnig / istock
It explains how GLP-1s work to treat diabetes and boost weight loss.
It also describes the various GLP-1s on the market and the differences between them.
GLP-1 receptor agonists belong to a class of medications known as incretin mimetics.
Get our printable guide for your next healthcare provider’s appointment to help you ask the right questions.
By mimicking the effects of GLP-1, the GLP-1 receptor agonists have many effects.
Some of their actions include:
GLP-1 agonists work on different organs throughout the body.
This can lead to weight loss.
In people with jot down 2 diabetes, glucagon can cause blood glucose levels to become too high.
Liver
GLP-1 lowers hepatic (liver) glucose output, which helps lower blood sugar levels.
This can limit how much a person eats and may ultimately lead to weight loss.
To self-inject a GLP-1 receptor agonist medication:
Never reuse or share supplies.
You should draw up your medication into a fresh syringe every time you self-inject.
Most pre-filled pens should be discarded after 30 days, even if they are unused.
you could talk to your pharmacist about the proper disposal of these supplies.
Side Effects
Overall, GLP-1 receptor agonists are safe and cause few side effects.
Other potential side effects of GLP-1 receptor agonists include constipation, bloating, indigestion, and headache.
There can also be some redness, itching, or soreness of the skin at the injection site.
Complications
In animal studies, both liraglutide and dulaglutide have been shown to promote thyroid cell tumors.
Who Should Avoid Them?
GLP-1 side effects are usually mild and include nausea, vomiting, diarrhea, and headache.
More serious side effects, including ongoing abdominal or allergic reactions, should be treated as an emergency.
Get our printable guide for your next healthcare provider’s appointment to help you ask the right questions.
2011;301(6):R1755R1764.
doi:10.1152/ajpregu.00472.2011
Gupta V.Glucagon-like peptide-1 analogues: An overview.Indian J Endocrinol Metab.
2017;10(4):178188.
Romera I, Cebrian-Cuenca A, Alvarez-Guisasola F, Gomez-Peralta F, Reviriego J.
2019;10(1):5-19. doi:10.1007/s13300-018-0535-9
